Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency.
about
Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Bilateral carcinoma in situ of ...... 21beta-hydroxylase deficiency.
@en
Bilateral carcinoma in situ of ...... membrane conductance regulator
@nl
type
label
Bilateral carcinoma in situ of ...... 21beta-hydroxylase deficiency.
@en
Bilateral carcinoma in situ of ...... membrane conductance regulator
@nl
prefLabel
Bilateral carcinoma in situ of ...... 21beta-hydroxylase deficiency.
@en
Bilateral carcinoma in situ of ...... membrane conductance regulator
@nl
P2093
P2860
P356
P1476
Bilateral carcinoma in situ of ...... 21beta-hydroxylase deficiency.
@en
P2093
L Foppiani
M C Patrosso
P De Cassan
P2860
P2888
P304
P356
10.1007/BF03351065
P577
2004-04-01T00:00:00Z